Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 5/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | EDNRB | P24530 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | EDNRA | P25101 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7396280 | 0.93 | HPGD (0.52) | HPGDNPC1LMNARAB9ASMN1; SMN2 | |
| SCHEMBL7403131 | 0.93 | HPGD (0.52) | HPGDNPC1LMNARAB9ASMN1; SMN2 | |
| SCHEMBL7396276 | 0.93 | HPGD (0.52) | HPGDNPC1LMNARAB9ASMN1; SMN2 | |
| SCHEMBL7401631 | 0.83 | HPGD (0.50) | HPGDNPC1LMNARAB9ASMN1; SMN2 | |
| SCHEMBL7397215 | 0.83 | ALDH1A1 (0.52) | HPGDNPC1LMNARAB9ASMN1; SMN2 | |
| SCHEMBL7401360 | 0.81 | ALDH1A1 (0.60) | HPGDNPC1LMNARAB9ASMN1; SMN2 | |
| SCHEMBL7398634 | 0.74 | HPGD (0.43) | HPGDNPC1LMNARAB9ASMN1; SMN2 | |
| SCHEMBL7398629 | 0.74 | HPGD (0.43) | HPGDNPC1LMNARAB9ASMN1; SMN2 | |
| SCHEMBL7404248 | 0.74 | EDNRB (0.61) | HPGDNPC1LMNARAB9ASMN1; SMN2 | |
| SCHEMBL7393005 | 0.73 | NPC1 (0.43) | HPGDNPC1LMNARAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0650484-B1 | ENDOTHELIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORP (US) | 2000-01-26 | — | — | EP | claimed |
| EP-0650484-B1 | ENDOTHELIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORP (US) | 2000-01-26 | — | — | EP | disclosed |
| US-5559105-A | ANTAGONIST FOR ENDOTHELIN RECEPTORS, HYPOTENSIVE AGENTS, TREATMENT OF KIDNEY FAILURE OR CEREBROVASCULAR DISORDERS | SMITHKLINE BEECHAM CORPORATION (US) | 1996-09-24 | — | — | US | disclosed |
| EP-0650484-A1 | ENDOTHELIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1995-05-03 | — | — | EP | disclosed |
| WO-1994002474-A1 | ENDOTHELIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1994-02-03 | — | — | WO | disclosed |